Abingdon
United Kingdom
49
2025-12-25
The entities that hold a legal rights for patent applications filed by inventor BROOKFIELD Frederick Arthur:
Frederick Arthur BROOKFIELD from Abingdon, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
METTL3 INHIBITORY COMPOUNDS
#2 | 2024-02-29Nitroxyl donors with improved therapeutic index
#3 | 2023-12-07METTL3 INHIBITORY COMPOUNDS
#4 | 2023-03-16METTL3 INHIBITORY COMPOUNDS
#5 | 2022-06-23Nitroxyl donors with improved therapeutic index
#6 | 2021-02-25N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#7 | 2021-01-21Nitroxyl donors with improved therapeutic index
#8 | 2020-04-23Nitroxyl donors with improved therapeutic index
#9 | 2020-03-19N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#10 | 2019-05-16N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#11 | 2019-05-09Nitroxyl donors with improved therapeutic index
#12 | 2018-11-08Pyrazolone derivatives as nitroxyl donors
#13 | 2018-10-25N-hydroxylsulfonamide derivatives as nitroxyl donors
#14 | 2018-08-30N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#15 | 2018-08-23Nitroxyl donors with improved therapeutic index
#16 | 2018-02-22N-ACYLOXYSULFONAMIDE AND N-HYDROXY-N-ACYLSULFONAMIDE DERIVATIVES
#17 | 2017-10-26N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#18 | 2017-06-01Nitroxyl donors with improved therapeutic index
#19 | 2017-01-26N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#20 | 2016-02-25Nitroso compounds as nitroxyl donors and methods of use thereof
#21 | 2016-02-18N-ACYLOXYSULFONAMIDE AND N-HYDROXY-N-ACYLSULFONAMIDE DERIVATIVES
#22 | 2016-02-18N-hydroxymethanesulfonamide nitroxyl donors
#23 | 2016-02-04Nitroxyl donors with improved therapeutic index
#24 | 2016-01-07-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#25 | 2015-12-03Pyrazolone derivatives as nitroxyl donors
#26 | 2015-11-26N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#27 | 2015-07-16Bis-acylated hydroxylamine derivatives
#28 | 2015-06-25Nitroxyl donors with improved therapeutic index
#29 | 2014-11-13N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#30 | 2014-11-13Nitroso compounds as nitroxyl donors and methods of use thereof
#31 | 2014-09-04Compounds
#32 | 2014-08-21N-ACYLOXYSULFONAMIDE AND N-HYDROXY-N-ACYLSULFONAMIDE DERIVATIVES
#33 | 2014-07-24Nitroxyl donors with improved therapeutic index
#34 | 2014-07-10N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#35 | 2013-02-21Nitroso compounds as nitroxyl donors and methods of use thereof
#36 | 2012-10-11-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#37 | 2012-08-16PI3 kinase inhibitors
#38 | 2011-12-15N-Hydroxylsulfonamide Derivatives as New Physiologically Useful Nitroxyl Donors
#39 | 2011-06-16N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
#40 | 2011-06-09Bis-acylated hydroxylamine derivatives
#41 | 2010-02-18MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL) ACETIC ACID
#42 | 2009-06-25N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#43 | 2009-01-22Treatment of CRTH2-mediated diseases and conditions
#44 | 2009-01-15Treatment of CRTH2-mediated diseases and conditions
#45 | 2009-01-15Treatment of CRTH2-mediated diseases and conditions
#46 | 2009-01-15Treatment of CRTH2-mediated diseases and conditions
#47 | 2007-12-27N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
#48 | 2007-10-04Compounds Having Crth2 Antagonist Activity
#49 | 2005-06-02Compounds for the treatment of CRTH2-mediated diseases and conditions
102091 ⎘